Authors:
Riess, FC
Fiege, M
Moshar, S
Bergmann, H
Bleese, N
Kormann, J
Weisshorn, R
Wappler, F
Citation: Fc. Riess et al., Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia, ANESTHESIOL, 94(2), 2001, pp. 355-357
Authors:
Wappler, F
Fiege, M
Steinfath, M
Agarwal, K
Scholz, J
Singh, S
Matschke, J
Esch, JSA
Citation: F. Wappler et al., Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis, ANESTHESIOL, 94(1), 2001, pp. 95-100
Authors:
Fiege, M
Wappler, F
Scholz, J
Weisshorn, R
von Richthofen, V
Esch, JSA
Citation: M. Fiege et al., Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients, J CLIN ANES, 12(2), 2000, pp. 123-128
Citation: F. Wappler et al., Hemodynamic and metabolic alterations in response to graded exercise in a patient susceptible to malignant hyperthermia, ANESTHESIOL, 92(1), 2000, pp. 268-272
Authors:
Baur, CP
Bellon, L
Felleiter, P
Fiege, M
Fricker, R
Glahn, K
Heffron, JJA
Herrmann-Frank, A
Jurkat-Rott, K
Klingler, W
Lehane, M
Ording, H
Tegazzin, V
Wappler, F
Georgieff, M
Lehmann-Horn, F
Citation: Cp. Baur et al., A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility, ANESTH ANAL, 90(1), 2000, pp. 200-205
Authors:
Wappler, F
Scholz, J
Fiege, M
Richter, A
Steinfath, M
Weisshorn, R
Esch, JSA
Citation: F. Wappler et al., 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients, N-S ARCH PH, 360(4), 1999, pp. 376-381
Authors:
Griesbeck, AG
Fiege, M
Gudipati, MS
Wagner, R
Citation: Ag. Griesbeck et al., Photooxygenation of 2,4-dimethyl-1,3-pentadiene: Solvent dependence of thechemical (ene reaction and [4+2] cycloaddition) and physical quenching of singlet oxygen, EUR J ORG C, (12), 1998, pp. 2833-2838